Foxy-5

DB13034InvestigationalSmall molecule

Foxy-5 has been used in trials studying the treatment of Prostate Cancer, Colorectal Cancer, Metastatic Colon Cancer, Metastatic Breast Cancer, and Metastatic Prostate Cancer.

Mechanism: Pharmacologically active on Protein Wnt-5a
Curator reviewed
Formula / weight: C₂₆H₄₂N₆O₁₂S₂ · 694.77 g/mol (avg)

Resolves to

Compound

UNIICBZ9UL0ARBCAS881188-51-8ChEBI125492PubChem44628955

Structure

InChIKeyWFZPJYYCTSHDJI-ATIWLJMLSA-NSMILESCSCC[C@H](NC=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O

Targets

P41221WNT5A

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Foxy-5, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account